• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么活体供肝移植在亚洲如此盛行?

Why does living donor liver transplantation flourish in Asia?

机构信息

Liver Transplant Program and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta-Pei Road, Niao-Sung, Kaohsiung, Taiwan 833.

出版信息

Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):746-51. doi: 10.1038/nrgastro.2013.194. Epub 2013 Oct 8.

DOI:10.1038/nrgastro.2013.194
PMID:24100300
Abstract

The success of liver transplantation worldwide has brought increased demand for the liver graft. Western and Asian countries have coped differently with the problems of the shortages in organ donation. In the West, efforts have focused on promoting deceased donor organ donation, whereas in Asia the focus has been on living donor liver transplantation (LDLT), as this procedure is more acceptable in most Asian cultures. LDLT, which was initially devised for paediatric liver transplant patients, has evolved from using a left lobe graft to a right lobe graft for an adult recipient. To widen the donor pool, dual grafts for a single recipient have been used in LDLT, and donors with hepatitis B core antibody positivity have been accepted, as well as ABO incompatible donors and recipients. The great advances in the field of LDLT have been dictated by the needs and the norms of Asian society. In this Perspectives article, we outline the reasons why LDLT flourishes in Asia.

摘要

全球肝移植的成功带来了对肝移植物的需求增加。西方和亚洲国家以不同的方式应对器官捐献短缺的问题。在西方,努力的重点是促进已故供体器官捐献,而在亚洲,重点则是活体肝移植(LDLT),因为这种手术在大多数亚洲文化中更能被接受。LDLT 最初是为儿科肝移植患者设计的,已经从使用左叶移植物发展为使用右叶移植物为成年受者进行移植。为了扩大供体库,在 LDLT 中使用了双移植物供一个受者,并接受了乙型肝炎核心抗体阳性的供者,以及 ABO 不相容的供者和受者。LDLT 领域的巨大进步是由亚洲社会的需求和规范决定的。在这篇观点文章中,我们概述了 LDLT 在亚洲蓬勃发展的原因。

相似文献

1
Why does living donor liver transplantation flourish in Asia?为什么活体供肝移植在亚洲如此盛行?
Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):746-51. doi: 10.1038/nrgastro.2013.194. Epub 2013 Oct 8.
2
Expanding the living liver donor pool in countries having limited deceased donor activity: Pakistani perspective.在有有限的已故供体活动的国家扩大活体肝移植供体库:巴基斯坦视角。
Transpl Immunol. 2022 Dec;75:101683. doi: 10.1016/j.trim.2022.101683. Epub 2022 Aug 9.
3
Liver transplantation in Asia: past, present and future.亚洲的肝移植:过去、现在与未来
Ann Acad Med Singap. 2009 Apr;38(4):322-10.
4
Living donor liver transplant (LDLT) is the way forward in Asia.活体供肝肝移植(LDLT)是亚洲的发展方向。
Hepatol Int. 2017 Mar;11(2):148-151. doi: 10.1007/s12072-016-9780-z. Epub 2017 Jan 17.
5
Asian contribution to living donor liver transplantation.亚洲对活体肝移植的贡献。
J Gastroenterol Hepatol. 2006 Mar;21(3):572-4. doi: 10.1111/j.1440-1746.2006.04283.x.
6
[Living Donor Liver Transplantation - Past and Present].[活体肝移植——过去与现在]
Zentralbl Chir. 2016 Oct;141(5):559-564. doi: 10.1055/s-0032-1328347. Epub 2013 Jul 3.
7
More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital.高雄长庚纪念医院超过四分之一个世纪的肝脏移植历程。
Clin Transpl. 2011:213-21.
8
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.肝移植供体与受体重比小于 0.8 不能排除成人-成人右半活体肝移植。
Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.
9
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients.成人对成人活体肝移植供受者安全性的临床研究
World J Gastroenterol. 2007 Feb 14;13(6):955-9. doi: 10.3748/wjg.v13.i6.955.
10
Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.采用 ABO 不相容和相容供肝的双活体供肝移植克服小体积供肝和 ABO 血型障碍。
Liver Transpl. 2010 Apr;16(4):491-8. doi: 10.1002/lt.22016.

引用本文的文献

1
Attitudes towards living organ donation: a cross-sectional survey study.对活体器官捐赠的态度:一项横断面调查研究。
Front Public Health. 2025 Mar 26;13:1552393. doi: 10.3389/fpubh.2025.1552393. eCollection 2025.
2
The Survival Rate of Living-Donor Liver Transplantation Between Same-Sex and Opposite-Sex Recipients.同性与异性受者活体肝移植的生存率
Diagnostics (Basel). 2025 Mar 18;15(6):757. doi: 10.3390/diagnostics15060757.
3
Progress of pediatric liver transplantation: In Japan and beyond.小儿肝移植的进展:日本及其他地区

本文引用的文献

1
The national program for deceased organ donation in China.中国的全国死亡器官捐献计划。
Transplantation. 2013 Jul 15;96(1):5-9. doi: 10.1097/TP.0b013e3182985491.
2
New era for organ donation and transplant in China. Interview by Fiona Fleck.中国器官捐献与移植的新时代。采访:菲奥娜·弗莱克。
Bull World Health Organ. 2012 Nov 1;90(11):802-3. doi: 10.2471/BLT.12.031112.
3
Early and long-term results of routine microsurgical biliary reconstruction in living donor liver transplantation.活体肝移植中常规显微胆重建的早期和长期结果。
Chin Med J (Engl). 2025 Apr 20;138(8):894-904. doi: 10.1097/CM9.0000000000003520. Epub 2025 Mar 27.
4
Pulmonary Embolism Following Living Donor Hepatectomy: A Report of 4 Cases and Literature Review.活体供肝肝切除术后肺栓塞:4例报告及文献复习
Ann Transplant. 2025 Feb 18;30:e946752. doi: 10.12659/AOT.946752.
5
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.肝细胞癌:流行病学、监测、诊断与治疗的最新进展
Clin Mol Hepatol. 2025 Feb;31(Suppl):S228-S254. doi: 10.3350/cmh.2024.0824. Epub 2024 Dec 26.
6
Trends of liver transplantation in Asia.亚洲肝脏移植的趋势。
Updates Surg. 2024 Jul 24. doi: 10.1007/s13304-024-01924-1.
7
Seventh Day Syndrome Revisited: Early Recognition of the Clinical Syndrome and an Evolving Understanding of Its Etiology.再探七日综合征:临床综合征的早期识别及其病因学的不断演变的认识
Front Transplant. 2022 Jun 28;1:913584. doi: 10.3389/frtra.2022.913584. eCollection 2022.
8
Defining Surgical Difficulty During Open Right Lobe Donor Hepatectomy and its Prediction Using Preoperative Donor Computed Tomography Morphometry.开放右叶供体肝切除术中手术难度的定义及其术前供体计算机断层扫描形态学预测
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101446. doi: 10.1016/j.jceh.2024.101446. Epub 2024 May 16.
9
A single center analysis of long-term outcomes and survival related risk factors in liver retransplantation.肝再次移植长期结局及生存相关危险因素的单中心分析
Hepatobiliary Surg Nutr. 2024 Jun 1;13(3):425-443. doi: 10.21037/hbsn-23-178. Epub 2023 Oct 21.
10
Usefulness of Diffusion-Weighted Imaging in Evaluating Acute Cellular Rejection and Monitoring Treatment Response in Liver Transplant Recipients.扩散加权成像在评估肝移植受者急性细胞排斥反应及监测治疗反应中的应用价值
Diagnostics (Basel). 2024 Apr 11;14(8):807. doi: 10.3390/diagnostics14080807.
Liver Transpl. 2013 Feb;19(2):207-14. doi: 10.1002/lt.23582.
4
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.全球丙型肝炎病毒感染的流行病学:特定年龄组丙型肝炎病毒抗体血清流行率的新估计。
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
5
More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital.高雄长庚纪念医院超过四分之一个世纪的肝脏移植历程。
Clin Transpl. 2011:213-21.
6
Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.亚洲共识研讨会报告:亚洲中晚期肝细胞癌管理专家共识指南。
Oncology. 2011;81 Suppl 1:158-64. doi: 10.1159/000333280. Epub 2011 Dec 22.
7
Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.脾切除术在术前使用利妥昔单抗的 ABO 不相容肝移植中不能提供免疫获益。
Transplantation. 2012 Jan 15;93(1):99-105. doi: 10.1097/TP.0b013e318239e8e4.
8
A pilot programme of organ donation after cardiac death in China.中国心脏死亡后器官捐献的试点项目。
Lancet. 2012 Mar 3;379(9818):862-5. doi: 10.1016/S0140-6736(11)61086-6. Epub 2011 Nov 10.
9
Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control.在成人对成人活体肝移植中,结合门静脉压力控制,移植物与受体体重比的下限可安全降至0.6%。
Transplant Proc. 2011 Jul-Aug;43(6):2391-3. doi: 10.1016/j.transproceed.2011.05.037.
10
Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis.ABO 血型不相容肝移植受者的结局:系统评价和荟萃分析。
PLoS One. 2011 Jan 25;6(1):e16521. doi: 10.1371/journal.pone.0016521.